michaeldlt

/Michael de la Torre

About Michael de la Torre

This author has not yet filled in any details.
So far Michael de la Torre has created 12 blog entries.
15 12, 2017

FDA Sent These 3 Warning Letters for Pharma Companies | November 2017

By | 2018-01-26T23:04:13+00:00 December 15th, 2017|Biopharma / Pharma, cGMP Quality Assurance and FDA 483s, FDA, FDA Warning Letters, FDAzilla|

We took a snapshot of the 3 warning letters the FDA sent to pharmaceutical companies last month.  Drug manufacturing violations ranged from failing to have correct expiration dates to failing to investigate the unexplained. From pharmaceuticals in China and India only, here they are (starting with the most recent): […]

16 11, 2017

FDA Sent These 6 Warning Letters for Pharma Companies | October 2017

By | 2018-01-26T23:06:27+00:00 November 16th, 2017|Biopharma / Pharma, FDA, FDA Warning Letters, FDAzilla|

We took a snapshot of the 6 warning letters the FDA sent to pharmaceutical companies last month.  Drug manufacturing violations ranged from failing to prevent “mix-ups” to failing to adequately investigate. From pharmaceuticals in Wisconsin, India, and more, here they are (starting with the most recent): […]

25 01, 2017

FSMA is Here. How Do You Manage 1,000 Food Suppliers?

By | 2018-02-13T10:54:31+00:00 January 25th, 2017|FDA, FDAzilla, Food, FOOD - Featured, quality assurance, Supplier Management|

FSMA is Here. How Do You Manage 1,000 Food Suppliers? The advent of the FSMA in the US means that everyone in your supplier network can expect an inspector to knock at some point, underlining the imperative for supplier accountability to compliance teams. Brand revenue and reputation ride on the outcome. […]